Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

After working for years to turn around its diabetes business, Medtronic announced plans on Wednesday to spin out the unit. The decision raised questions among analysts about why Medtronic would exit a ...

Medtronic’s decision to split its diabetes unit into a separate business is expected to improve its financial performance in the diabetes space. Image credit: JHVEPhoto / Shutterstock.com Medtronic ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating ...

Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year ...

Medtronic is among the world’s largest makers of medical devices. - Jenn Ackerman for WSJ Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the ...

Medtronic said Wednesday that it plans to spin off its diabetes business in the next 18 months, creating a new diabetes technology company that can offer customers both insulin pumps and ...

The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into ...

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...

Medtronic plans diabetes unit spin-off via IPO and split-off Fiscal 2026 earnings forecast below Wall Street estimates Tariff impact on 2026 costs estimated at $200-$350 million May 21 (Reuters ...

A Micra AV pacemaker is on display. (Photo by Tang Yanjun/China News Service via Getty Images) Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last ...

Medtronic has won Food and Drug Administration approval for the Omniasecure defibrillation lead, the company said Friday. The lead connects to an implantable defibrillator and treats potentially life ...